Literature DB >> 29985475

Multidimensional communication in the microenvirons of glioblastoma.

Marike L Broekman1,2, Sybren L N Maas3,4, Erik R Abels3, Thorsten R Mempel5,6, Anna M Krichevsky7, Xandra O Breakefield8.   

Abstract

Glioblastomas are heterogeneous and invariably lethal tumours. They are characterized by genetic and epigenetic variations among tumour cells, which makes the development of therapies that eradicate all tumour cells challenging and currently impossible. An important component of glioblastoma growth is communication with and manipulation of other cells in the brain environs, which supports tumour progression and resistance to therapy. Glioblastoma cells recruit innate immune cells and change their phenotype to support tumour growth. Tumour cells also suppress adaptive immune responses, and our increasing understanding of how T cells access the brain and how the tumour thwarts the immune response offers new strategies for mobilizing an antitumour response. Tumours also subvert normal brain cells - including endothelial cells, neurons and astrocytes - to create a microenviron that favours tumour success. Overall, after glioblastoma-induced phenotypic modifications, normal cells cooperate with tumour cells to promote tumour proliferation, invasion of the brain, immune suppression and angiogenesis. This glioblastoma takeover of the brain involves multiple modes of communication, including soluble factors such as chemokines and cytokines, direct cell-cell contact, extracellular vesicles (including exosomes and microvesicles) and connecting nanotubes and microtubes. Understanding these multidimensional communications between the tumour and the cells in its environs could open new avenues for therapy.

Entities:  

Mesh:

Year:  2018        PMID: 29985475      PMCID: PMC6425928          DOI: 10.1038/s41582-018-0025-8

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  167 in total

1.  Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.

Authors:  Michael B Dinkins; Somsankar Dasgupta; Guanghu Wang; Gu Zhu; Erhard Bieberich
Journal:  Neurobiol Aging       Date:  2014-02-15       Impact factor: 4.673

Review 2.  Extracellular Vesicles: Unique Intercellular Delivery Vehicles.

Authors:  Sybren L N Maas; Xandra O Breakefield; Alissa M Weaver
Journal:  Trends Cell Biol       Date:  2016-12-13       Impact factor: 20.808

3.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

4.  RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma.

Authors:  Xuebo Chen; Leying Zhang; Ian Y Zhang; Junling Liang; Huaqing Wang; Mao Ouyang; Shihua Wu; Anna Carolina Carvalho da Fonseca; Lihong Weng; Yasuhiko Yamamoto; Hiroshi Yamamoto; Rama Natarajan; Behnam Badie
Journal:  Cancer Res       Date:  2014-10-17       Impact factor: 12.701

5.  Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model.

Authors:  Onyinyechukwu Okolie; Juli R Bago; Ralf S Schmid; David M Irvin; Ryan E Bash; C Ryan Miller; Shawn D Hingtgen
Journal:  Neuro Oncol       Date:  2016-06-13       Impact factor: 12.300

6.  Hyaluronan production enhances shedding of plasma membrane-derived microvesicles.

Authors:  Kirsi Rilla; Sanna Pasonen-Seppänen; Ashik J Deen; Ville V T Koistinen; Sara Wojciechowski; Sanna Oikari; Riikka Kärnä; Genevieve Bart; Kari Törrönen; Raija H Tammi; Markku I Tammi
Journal:  Exp Cell Res       Date:  2013-06-01       Impact factor: 3.905

7.  Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.

Authors:  Arezu Jahani-Asl; Hang Yin; Vahab D Soleimani; Takrima Haque; H Artee Luchman; Natasha C Chang; Marie-Claude Sincennes; Sidharth V Puram; Andrew M Scott; Ian A J Lorimer; Theodore J Perkins; Keith L Ligon; Samuel Weiss; Michael A Rudnicki; Azad Bonni
Journal:  Nat Neurosci       Date:  2016-04-25       Impact factor: 24.884

8.  Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging.

Authors:  Xin Mei; Yin-Sheng Chen; Fu-Rong Chen; Shao-Yan Xi; Zhong-Ping Chen
Journal:  Neuro Oncol       Date:  2017-08-01       Impact factor: 12.300

9.  Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas.

Authors:  Konrad Gabrusiewicz; Aleksandra Ellert-Miklaszewska; Maciej Lipko; Malgorzata Sielska; Marta Frankowska; Bozena Kaminska
Journal:  PLoS One       Date:  2011-08-25       Impact factor: 3.240

10.  Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.

Authors:  Frank Szulzewsky; Andreas Pelz; Xi Feng; Michael Synowitz; Darko Markovic; Thomas Langmann; Inge R Holtman; Xi Wang; Bart J L Eggen; Hendrikus W G M Boddeke; Dolores Hambardzumyan; Susanne A Wolf; Helmut Kettenmann
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

View more
  142 in total

Review 1.  TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme-Future Perspectives.

Authors:  Jakub Litak; Cezary Grochowski; Joanna Litak; Ida Osuchowska; Krzysztof Gosik; Elżbieta Radzikowska; Piotr Kamieniak; Jacek Rolinski
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

Review 2.  Tumor-derived extracellular vesicles: molecular parcels that enable regulation of the immune response in cancer.

Authors:  Colin Sheehan; Crislyn D'Souza-Schorey
Journal:  J Cell Sci       Date:  2019-10-15       Impact factor: 5.285

Review 3.  Molecular chaperones in the brain endothelial barrier: neurotoxicity or neuroprotection?

Authors:  Dominique Thuringer; Carmen Garrido
Journal:  FASEB J       Date:  2019-07-26       Impact factor: 5.191

4.  Glioblastoma single extracellular vesicle analysis profiles: wading into new oceans of tumor data.

Authors:  Jennifer Jones
Journal:  Neuro Oncol       Date:  2019-05-06       Impact factor: 12.300

Review 5.  BCL2L13: physiological and pathological meanings.

Authors:  Fei Meng; Naitong Sun; Dongyan Liu; Jia Jia; Jun Xiao; Haiming Dai
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

6.  Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.

Authors:  Jiping Wang; Jianmei W Leavenworth; Anita B Hjelmeland; Reed Smith; Neha Patel; Ben Borg; Ying Si; Peter H King
Journal:  Glia       Date:  2019-08-10       Impact factor: 7.452

7.  Extracellular Vesicle Mediated Vascular Pathology in Glioblastoma.

Authors:  Cristiana Spinelli; Nadim Tawil; Lata Adnani; Janusz Rak; Dongsic Choi
Journal:  Subcell Biochem       Date:  2021

Review 8.  Glioma EVs Contribute to Immune Privilege in the Brain.

Authors:  Erik R Abels; Marike L D Broekman; Xandra O Breakefield; Sybren L N Maas
Journal:  Trends Cancer       Date:  2019-06-04

Review 9.  microRNA and exosome profiling in multiple sclerosis.

Authors:  Marcin P Mycko; Sergio E Baranzini
Journal:  Mult Scler       Date:  2020-01-22       Impact factor: 6.312

Review 10.  Extracellular Vesicle-Mediated Bilateral Communication between Glioblastoma and Astrocytes.

Authors:  Lisa Nieland; Liza M Morsett; Marike L D Broekman; Xandra O Breakefield; Erik R Abels
Journal:  Trends Neurosci       Date:  2020-11-21       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.